Time For Independent FDA? COVID-19 Political Pressure Reignites Debate

The political spotlight on the Food & Drug Administration during the COVID-19 pandemic has renewed the long-standing debate as to whether FDA should be made an independent, Cabinet-level federal agency and freed from direct HHS oversight.

FDABldg1ExteriorWithCircle_1200x675
Will there be renewed momentum to make the FDA independent of HHS as a result of the pandemic? • Source: File photo

More from US FDA

More from Agency Leadership